COVID-19 Impact on Global Cardiac Biomarkers Testing Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: C3CDF73C8793EN
QYResearch

Abstracts

This report focuses on the global Cardiac Biomarkers Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cardiac Biomarkers Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbott Laboratories
• Becton, Dickinson and Company
• BioMerieux
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• ROCHE
• Siemens AG
• Thermo Fisher Scientific, Inc.
• PerkinElmer Inc.
• Tosoh Corporation

Market segment by Type, the product can be split into

• Myocardial Muscle Creatine Kinase (CK-MB)
• Troponins (T and I)
• Myoglobin
• Brain Natriuretic Peptide (BNPs) or NT-proBNP
• Ischemia-modified Albumin (IMA)
• Others

Market segment by Application, split into

• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Atherosclerosis
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cardiac Biomarkers Testing status, future forecast, growth opportunity, key market and key players.
• To present the Cardiac Biomarkers Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cardiac Biomarkers Testing are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cardiac Biomarkers Testing Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cardiac Biomarkers Testing Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Myocardial Muscle Creatine Kinase (CK-MB)
  1.4.3 Troponins (T and I)
  1.4.4 Myoglobin
  1.4.5 Brain Natriuretic Peptide (BNPs) or NT-proBNP
  1.4.6 Ischemia-modified Albumin (IMA)
  1.4.7 Others
1.5 Market by Application
  1.5.1 Global Cardiac Biomarkers Testing Market Share by Application: 2020 VS 2026
  1.5.2 Myocardial Infarction
  1.5.3 Congestive Heart Failure
  1.5.4 Acute Coronary Syndrome
  1.5.5 Atherosclerosis
  1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Cardiac Biomarkers Testing Industry Impact
  1.6.1 How the Covid-19 is Affecting the Cardiac Biomarkers Testing Industry
    1.6.1.1 Cardiac Biomarkers Testing Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Cardiac Biomarkers Testing Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Cardiac Biomarkers Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cardiac Biomarkers Testing Market Perspective (2015-2026)
2.2 Cardiac Biomarkers Testing Growth Trends by Regions
  2.2.1 Cardiac Biomarkers Testing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cardiac Biomarkers Testing Historic Market Share by Regions (2015-2020)
  2.2.3 Cardiac Biomarkers Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cardiac Biomarkers Testing Market Growth Strategy
  2.3.6 Primary Interviews with Key Cardiac Biomarkers Testing Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cardiac Biomarkers Testing Players by Market Size
  3.1.1 Global Top Cardiac Biomarkers Testing Players by Revenue (2015-2020)
  3.1.2 Global Cardiac Biomarkers Testing Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cardiac Biomarkers Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cardiac Biomarkers Testing Market Concentration Ratio
  3.2.1 Global Cardiac Biomarkers Testing Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cardiac Biomarkers Testing Revenue in 2019
3.3 Cardiac Biomarkers Testing Key Players Head office and Area Served
3.4 Key Players Cardiac Biomarkers Testing Product Solution and Service
3.5 Date of Enter into Cardiac Biomarkers Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cardiac Biomarkers Testing Historic Market Size by Type (2015-2020)
4.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Type (2021-2026)

5 CARDIAC BIOMARKERS TESTING BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cardiac Biomarkers Testing Market Size by Application (2015-2020)
5.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cardiac Biomarkers Testing Market Size (2015-2020)
6.2 Cardiac Biomarkers Testing Key Players in North America (2019-2020)
6.3 North America Cardiac Biomarkers Testing Market Size by Type (2015-2020)
6.4 North America Cardiac Biomarkers Testing Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cardiac Biomarkers Testing Market Size (2015-2020)
7.2 Cardiac Biomarkers Testing Key Players in Europe (2019-2020)
7.3 Europe Cardiac Biomarkers Testing Market Size by Type (2015-2020)
7.4 Europe Cardiac Biomarkers Testing Market Size by Application (2015-2020)

8 CHINA

8.1 China Cardiac Biomarkers Testing Market Size (2015-2020)
8.2 Cardiac Biomarkers Testing Key Players in China (2019-2020)
8.3 China Cardiac Biomarkers Testing Market Size by Type (2015-2020)
8.4 China Cardiac Biomarkers Testing Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cardiac Biomarkers Testing Market Size (2015-2020)
9.2 Cardiac Biomarkers Testing Key Players in Japan (2019-2020)
9.3 Japan Cardiac Biomarkers Testing Market Size by Type (2015-2020)
9.4 Japan Cardiac Biomarkers Testing Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cardiac Biomarkers Testing Market Size (2015-2020)
10.2 Cardiac Biomarkers Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cardiac Biomarkers Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Cardiac Biomarkers Testing Market Size by Application (2015-2020)

11 INDIA

11.1 India Cardiac Biomarkers Testing Market Size (2015-2020)
11.2 Cardiac Biomarkers Testing Key Players in India (2019-2020)
11.3 India Cardiac Biomarkers Testing Market Size by Type (2015-2020)
11.4 India Cardiac Biomarkers Testing Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cardiac Biomarkers Testing Market Size (2015-2020)
12.2 Cardiac Biomarkers Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Cardiac Biomarkers Testing Market Size by Type (2015-2020)
12.4 Central & South America Cardiac Biomarkers Testing Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Details
  13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.1.3 Abbott Laboratories Cardiac Biomarkers Testing Introduction
  13.1.4 Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2015-2020))
  13.1.5 Abbott Laboratories Recent Development
13.2 Becton, Dickinson and Company
  13.2.1 Becton, Dickinson and Company Company Details
  13.2.2 Becton, Dickinson and Company Business Overview and Its Total Revenue
  13.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Introduction
  13.2.4 Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2015-2020)
  13.2.5 Becton, Dickinson and Company Recent Development
13.3 BioMerieux
  13.3.1 BioMerieux Company Details
  13.3.2 BioMerieux Business Overview and Its Total Revenue
  13.3.3 BioMerieux Cardiac Biomarkers Testing Introduction
  13.3.4 BioMerieux Revenue in Cardiac Biomarkers Testing Business (2015-2020)
  13.3.5 BioMerieux Recent Development
13.4 Bio-Rad Laboratories, Inc.
  13.4.1 Bio-Rad Laboratories, Inc. Company Details
  13.4.2 Bio-Rad Laboratories, Inc. Business Overview and Its Total Revenue
  13.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Introduction
  13.4.4 Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2015-2020)
  13.4.5 Bio-Rad Laboratories, Inc. Recent Development
13.5 Danaher Corporation
  13.5.1 Danaher Corporation Company Details
  13.5.2 Danaher Corporation Business Overview and Its Total Revenue
  13.5.3 Danaher Corporation Cardiac Biomarkers Testing Introduction
  13.5.4 Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2015-2020)
  13.5.5 Danaher Corporation Recent Development
13.6 ROCHE
  13.6.1 ROCHE Company Details
  13.6.2 ROCHE Business Overview and Its Total Revenue
  13.6.3 ROCHE Cardiac Biomarkers Testing Introduction
  13.6.4 ROCHE Revenue in Cardiac Biomarkers Testing Business (2015-2020)
  13.6.5 ROCHE Recent Development
13.7 Siemens AG
  13.7.1 Siemens AG Company Details
  13.7.2 Siemens AG Business Overview and Its Total Revenue
  13.7.3 Siemens AG Cardiac Biomarkers Testing Introduction
  13.7.4 Siemens AG Revenue in Cardiac Biomarkers Testing Business (2015-2020)
  13.7.5 Siemens AG Recent Development
13.8 Thermo Fisher Scientific, Inc.
  13.8.1 Thermo Fisher Scientific, Inc. Company Details
  13.8.2 Thermo Fisher Scientific, Inc. Business Overview and Its Total Revenue
  13.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Introduction
  13.8.4 Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2015-2020)
  13.8.5 Thermo Fisher Scientific, Inc. Recent Development
13.9 PerkinElmer Inc.
  13.9.1 PerkinElmer Inc. Company Details
  13.9.2 PerkinElmer Inc. Business Overview and Its Total Revenue
  13.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Introduction
  13.9.4 PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2015-2020)
  13.9.5 PerkinElmer Inc. Recent Development
13.10 Tosoh Corporation
  13.10.1 Tosoh Corporation Company Details
  13.10.2 Tosoh Corporation Business Overview and Its Total Revenue
  13.10.3 Tosoh Corporation Cardiac Biomarkers Testing Introduction
  13.10.4 Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2015-2020)
  13.10.5 Tosoh Corporation Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cardiac Biomarkers Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Cardiac Biomarkers Testing Revenue
Table 3. Ranking of Global Top Cardiac Biomarkers Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cardiac Biomarkers Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Myocardial Muscle Creatine Kinase (CK-MB)
Table 6. Key Players of Troponins (T and I)
Table 7. Key Players of Myoglobin
Table 8. Key Players of Brain Natriuretic Peptide (BNPs) or NT-proBNP
Table 9. Key Players of Ischemia-modified Albumin (IMA)
Table 10. Key Players of Others
Table 11. COVID-19 Impact Global Market: (Four Cardiac Biomarkers Testing Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Cardiac Biomarkers Testing Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Cardiac Biomarkers Testing Players to Combat Covid-19 Impact
Table 16. Global Cardiac Biomarkers Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Cardiac Biomarkers Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Cardiac Biomarkers Testing Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Cardiac Biomarkers Testing Market Share by Regions (2015-2020)
Table 20. Global Cardiac Biomarkers Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Cardiac Biomarkers Testing Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Cardiac Biomarkers Testing Market Growth Strategy
Table 26. Main Points Interviewed from Key Cardiac Biomarkers Testing Players
Table 27. Global Cardiac Biomarkers Testing Revenue by Players (2015-2020) (Million US$)
Table 28. Global Cardiac Biomarkers Testing Market Share by Players (2015-2020)
Table 29. Global Top Cardiac Biomarkers Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Biomarkers Testing as of 2019)
Table 30. Global Cardiac Biomarkers Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Cardiac Biomarkers Testing Product Solution and Service
Table 33. Date of Enter into Cardiac Biomarkers Testing Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Cardiac Biomarkers Testing Market Size by Type (2015-2020) (Million US$)
Table 36. Global Cardiac Biomarkers Testing Market Size Share by Type (2015-2020)
Table 37. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2021-2026)
Table 38. Global Cardiac Biomarkers Testing Market Size Share by Application (2015-2020)
Table 39. Global Cardiac Biomarkers Testing Market Size by Application (2015-2020) (Million US$)
Table 40. Global Cardiac Biomarkers Testing Market Size Share by Application (2021-2026)
Table 41. North America Key Players Cardiac Biomarkers Testing Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Cardiac Biomarkers Testing Market Share (2019-2020)
Table 43. North America Cardiac Biomarkers Testing Market Size by Type (2015-2020) (Million US$)
Table 44. North America Cardiac Biomarkers Testing Market Share by Type (2015-2020)
Table 45. North America Cardiac Biomarkers Testing Market Size by Application (2015-2020) (Million US$)
Table 46. North America Cardiac Biomarkers Testing Market Share by Application (2015-2020)
Table 47. Europe Key Players Cardiac Biomarkers Testing Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Cardiac Biomarkers Testing Market Share (2019-2020)
Table 49. Europe Cardiac Biomarkers Testing Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Cardiac Biomarkers Testing Market Share by Type (2015-2020)
Table 51. Europe Cardiac Biomarkers Testing Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Cardiac Biomarkers Testing Market Share by Application (2015-2020)
Table 53. China Key Players Cardiac Biomarkers Testing Revenue (2019-2020) (Million US$)
Table 54. China Key Players Cardiac Biomarkers Testing Market Share (2019-2020)
Table 55. China Cardiac Biomarkers Testing Market Size by Type (2015-2020) (Million US$)
Table 56. China Cardiac Biomarkers Testing Market Share by Type (2015-2020)
Table 57. China Cardiac Biomarkers Testing Market Size by Application (2015-2020) (Million US$)
Table 58. China Cardiac Biomarkers Testing Market Share by Application (2015-2020)
Table 59. Japan Key Players Cardiac Biomarkers Testing Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Cardiac Biomarkers Testing Market Share (2019-2020)
Table 61. Japan Cardiac Biomarkers Testing Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Cardiac Biomarkers Testing Market Share by Type (2015-2020)
Table 63. Japan Cardiac Biomarkers Testing Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Cardiac Biomarkers Testing Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Cardiac Biomarkers Testing Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Cardiac Biomarkers Testing Market Share (2019-2020)
Table 67. Southeast Asia Cardiac Biomarkers Testing Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Cardiac Biomarkers Testing Market Share by Type (2015-2020)
Table 69. Southeast Asia Cardiac Biomarkers Testing Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Cardiac Biomarkers Testing Market Share by Application (2015-2020)
Table 71. India Key Players Cardiac Biomarkers Testing Revenue (2019-2020) (Million US$)
Table 72. India Key Players Cardiac Biomarkers Testing Market Share (2019-2020)
Table 73. India Cardiac Biomarkers Testing Market Size by Type (2015-2020) (Million US$)
Table 74. India Cardiac Biomarkers Testing Market Share by Type (2015-2020)
Table 75. India Cardiac Biomarkers Testing Market Size by Application (2015-2020) (Million US$)
Table 76. India Cardiac Biomarkers Testing Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Cardiac Biomarkers Testing Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Cardiac Biomarkers Testing Market Share (2019-2020)
Table 79. Central & South America Cardiac Biomarkers Testing Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Cardiac Biomarkers Testing Market Share by Type (2015-2020)
Table 81. Central & South America Cardiac Biomarkers Testing Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Cardiac Biomarkers Testing Market Share by Application (2015-2020)
Table 83. Abbott Laboratories Company Details
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Product
Table 86. Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2015-2020) (Million US$)
Table 87. Abbott Laboratories Recent Development
Table 88. Becton, Dickinson and Company Company Details
Table 89. Becton, Dickinson and Company Business Overview
Table 90. Becton, Dickinson and Company Product
Table 91. Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2015-2020) (Million US$)
Table 92. Becton, Dickinson and Company Recent Development
Table 93. BioMerieux Company Details
Table 94. BioMerieux Business Overview
Table 95. BioMerieux Product
Table 96. BioMerieux Revenue in Cardiac Biomarkers Testing Business (2015-2020) (Million US$)
Table 97. BioMerieux Recent Development
Table 98. Bio-Rad Laboratories, Inc. Company Details
Table 99. Bio-Rad Laboratories, Inc. Business Overview
Table 100. Bio-Rad Laboratories, Inc. Product
Table 101. Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2015-2020) (Million US$)
Table 102. Bio-Rad Laboratories, Inc. Recent Development
Table 103. Danaher Corporation Company Details
Table 104. Danaher Corporation Business Overview
Table 105. Danaher Corporation Product
Table 106. Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2015-2020) (Million US$)
Table 107. Danaher Corporation Recent Development
Table 108. ROCHE Company Details
Table 109. ROCHE Business Overview
Table 110. ROCHE Product
Table 111. ROCHE Revenue in Cardiac Biomarkers Testing Business (2015-2020) (Million US$)
Table 112. ROCHE Recent Development
Table 113. Siemens AG Company Details
Table 114. Siemens AG Business Overview
Table 115. Siemens AG Product
Table 116. Siemens AG Revenue in Cardiac Biomarkers Testing Business (2015-2020) (Million US$)
Table 117. Siemens AG Recent Development
Table 118. Thermo Fisher Scientific, Inc. Business Overview
Table 119. Thermo Fisher Scientific, Inc. Product
Table 120. Thermo Fisher Scientific, Inc. Company Details
Table 121. Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2015-2020) (Million US$)
Table 122. Thermo Fisher Scientific, Inc. Recent Development
Table 123. PerkinElmer Inc. Company Details
Table 124. PerkinElmer Inc. Business Overview
Table 125. PerkinElmer Inc. Product
Table 126. PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2015-2020) (Million US$)
Table 127. PerkinElmer Inc. Recent Development
Table 128. Tosoh Corporation Company Details
Table 129. Tosoh Corporation Business Overview
Table 130. Tosoh Corporation Product
Table 131. Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2015-2020) (Million US$)
Table 132. Tosoh Corporation Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cardiac Biomarkers Testing Market Share by Type: 2020 VS 2026
Figure 2. Myocardial Muscle Creatine Kinase (CK-MB) Features
Figure 3. Troponins (T and I) Features
Figure 4. Myoglobin Features
Figure 5. Brain Natriuretic Peptide (BNPs) or NT-proBNP Features
Figure 6. Ischemia-modified Albumin (IMA) Features
Figure 7. Others Features
Figure 8. Global Cardiac Biomarkers Testing Market Share by Application: 2020 VS 2026
Figure 9. Myocardial Infarction Case Studies
Figure 10. Congestive Heart Failure Case Studies
Figure 11. Acute Coronary Syndrome Case Studies
Figure 12. Atherosclerosis Case Studies
Figure 13. Others Case Studies
Figure 14. Cardiac Biomarkers Testing Report Years Considered
Figure 15. Global Cardiac Biomarkers Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Cardiac Biomarkers Testing Market Share by Regions: 2020 VS 2026
Figure 17. Global Cardiac Biomarkers Testing Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Cardiac Biomarkers Testing Market Share by Players in 2019
Figure 20. Global Top Cardiac Biomarkers Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Biomarkers Testing as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Cardiac Biomarkers Testing Revenue in 2019
Figure 22. North America Cardiac Biomarkers Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Cardiac Biomarkers Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Cardiac Biomarkers Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Cardiac Biomarkers Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Cardiac Biomarkers Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Cardiac Biomarkers Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Cardiac Biomarkers Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Abbott Laboratories Revenue Growth Rate in Cardiac Biomarkers Testing Business (2015-2020)
Figure 31. Becton, Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Becton, Dickinson and Company Revenue Growth Rate in Cardiac Biomarkers Testing Business (2015-2020)
Figure 33. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. BioMerieux Revenue Growth Rate in Cardiac Biomarkers Testing Business (2015-2020)
Figure 35. Bio-Rad Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2015-2020)
Figure 37. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Danaher Corporation Revenue Growth Rate in Cardiac Biomarkers Testing Business (2015-2020)
Figure 39. ROCHE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. ROCHE Revenue Growth Rate in Cardiac Biomarkers Testing Business (2015-2020)
Figure 41. Siemens AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Siemens AG Revenue Growth Rate in Cardiac Biomarkers Testing Business (2015-2020)
Figure 43. Thermo Fisher Scientific, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2015-2020)
Figure 45. PerkinElmer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. PerkinElmer Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2015-2020)
Figure 47. Tosoh Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Tosoh Corporation Revenue Growth Rate in Cardiac Biomarkers Testing Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed